FOR INVESTORS

The Infrastructure Layer
for Clinical AI.

129 countries have digital health strategies. AI agents are multiplying across clinical workflows. But there is no global registry for discovery, no open protocol for delegation, and no trust framework for clinical safety. Symphonix Health is building all three.

Request Investor Briefing View Market Data
THE OPPORTUNITY

Healthcare AI has no plumbing.

Hospitals are adopting AI agents for triage, diagnostics, scheduling, and clinical decision support. But every deployment is bespoke. There is no DNS for clinical agents, no routing layer, no trust registry. Symphonix Health is building the infrastructure that makes clinical AI discoverable, verifiable, and safe.

$36.7B
Healthcare AI market (2025)
Grand View Research
$1.1B
Agentic AI in healthcare (2025)
Grand View Research
$22.5B
Healthcare cybersecurity (2025)
Fortune Business Insights
$420B
Global digital health (2025)
Fortune Business Insights
WHY NOW

Four forces converging.

The Agent Explosion

61% of healthcare leaders are already building agentic AI initiatives. 85% plan to increase investment over the next 2–3 years. Clinical AI agents are multiplying, but there is no standard for how they discover, trust, or delegate to each other.

The Interoperability Wave

TEFCA has grown from 10 million to nearly 500 million health records exchanged in 2025 alone. Hospital participation in interoperability networks jumped from 10% to 39% in a single year. The infrastructure layer for health data exchange is being built now.

The Regulatory Tailwind

The EU AI Act requires transparency and audit trails for clinical AI. GDPR mandates data sovereignty. 129 countries have national digital health strategies. Regulators are demanding exactly what Symphonix builds: governed, auditable AI infrastructure.

The Africa Leapfrog

1.4 billion people. 54 nations building digital health without legacy debt. Africa can skip the fragmented EHR era and go directly to AI-native infrastructure — the same way it leapfrogged landlines with mobile phones. A $5.6B market growing at 23–42% CAGR.

THE PLATFORM

Four products. One protocol standard.

Each product addresses a distinct infrastructure gap. Together, they form the complete trust and routing layer for clinical AI.

HEALTH INFORMATION EXCHANGE

BulletTrain

AI-native Health Information Exchange built on the OpenHIE framework. 160+ microservices implementing the mediator pattern across every major healthcare standard — HL7 FHIR, DICOM, CDA, X12, NCPDP.

Enterprise licence. The governed data layer that connects clinical systems, AI agents, and health data sources within and across health systems.
AGENT REGISTRY

GHARRA

Global Healthcare Agent Registry and Routing Authority. A federated, zero-trust registry for AI agent discovery, capability verification, and clinical risk scoring. The DNS of clinical AI.

Managed service hosted by Symphonix Health, charged per agent usage. Every agent registered increases the network’s value. Root node operates from Dublin with federated regional nodes deployable within national data boundaries.
AA
AGENT PROTOCOL

Nexus A2A

Agent-to-Agent communication protocol for secure clinical delegation. JSON-RPC 2.0 with SSE and WebSocket transport. Consent enforcement, hash-chained audit trails, and clinical safety constraints built into the protocol layer.

Governed protocol standard. Once hospitals adopt Nexus A2A as their agent communication standard, switching costs create durable lock-in at the protocol level.
CLINICAL AI

Bevan LLM

Clinical language model named for Aneurin Bevan, architect of the NHS. Purpose-built for healthcare reasoning with clinical safety guardrails, evidence grounding, and audit transparency.

Named for the principle that intelligent healthcare reasoning should be available to every health system — not just those that can afford proprietary cloud AI.
ADDRESSABLE MARKET

Multi-market infrastructure play.

Symphonix products sit at the intersection of three high-growth markets. Each product addresses a distinct market segment; together they compound into a platform-scale opportunity.

$36.7B
Healthcare AI
GHARRA, Nexus A2A, and Bevan LLM collectively address the infrastructure layer of clinical AI — discovery, routing, trust, and reasoning.
38.9% CAGR → $506B by 2033
$22.5B
Healthcare Cybersecurity
GHARRA’s zero-trust agent verification, mTLS, DPoP authentication, and hash-chained audit trails address the trust and security layer of clinical AI.
18.5% CAGR → $47.9B by 2030
$5.6B
Africa Digital Health
BulletTrain’s HIE, combined with GHARRA’s federated architecture, enables leapfrog deployment in 54 African nations building AI-native health systems.
23–42% CAGR → $8.4B by 2029
COMPETITIVE MOAT

Four layers of defensibility.

Network Effects

Every agent registered on GHARRA makes the network more valuable for discovery and routing. Every health system connected to BulletTrain increases the data available for clinical AI. Classic two-sided network economics.

Protocol Lock-in

Once hospitals adopt Nexus A2A for agent-to-agent communication, switching costs are structural. Clinical workflows, audit trails, and consent chains are woven into the protocol. Changing protocols means rewiring the entire agent ecosystem.

Regulatory Alignment

EU AI Act, GDPR, and HIPAA demand exactly what Symphonix builds: transparency, audit trails, data sovereignty, and governed AI. Compliance is not a feature — it is the architecture. Competitors would need to rebuild from the ground up.

Geographic First-Mover

Dublin headquarters provides GDPR adequacy and EU AI Act compliance. Ireland sits between the UK, EU, and African health systems. The GHARRA root node in Dublin is the trust anchor for the global federated network. No competitor occupies this position.

BUSINESS MODEL

Open core. Enterprise revenue.

Open protocols build adoption and trust. Enterprise products and services generate revenue. The model mirrors successful infrastructure companies: open standards create the market; commercial products capture value.

$
PLATFORM

BulletTrain Enterprise

Annual subscription for the AI-native Health Information Exchange. Tiered by connected systems, transaction volume, and deployment model (cloud, sovereign, on-premises). Includes dedicated support and SLA guarantees.

REGISTRY

GHARRA Registry Fees

Per-agent registration and verification fees for the Global Agent Registry. Tiered pricing by trust level, jurisdiction, and federation scope. Enterprise plans for health systems registering multiple agents.

TX
PROTOCOL

Nexus A2A Transaction Fees

Per-transaction fees for clinical delegations routed through the Nexus protocol. Volume-based pricing with enterprise committed-use discounts. Revenue scales linearly with agent ecosystem growth.

SERVICES

Professional Services

Healthcare AI strategy consultancy, architecture workshops, implementation support, clinical governance advisory, and cybersecurity assessments. Strategy sessions, workshops, and ongoing engagement models.

TRACTION & MILESTONES

From build to market.

2024

Founded

Symphonix Health incorporated in Dublin, Ireland. Architecture design for BulletTrain, GHARRA, and Nexus A2A completed. Core team assembled.

2026 — NOW

Platform Launch

Nexus A2A protocol and GHARRA managed service launched. GHARRA root node live in Dublin. BulletTrain free to install and self-host. Advisory board formed.

2026–2027

First Revenue

Enterprise pilot deployments. First BulletTrain subscriptions. GHARRA federation with regional nodes. Africa market entry through partnership channels.

2027–2028

Scale

Multi-country GHARRA federation. Nexus A2A adoption as de facto standard. BulletTrain deployments across multiple health systems. Series A readiness.

INVESTMENT THESIS

Why Symphonix Health.

The case for infrastructure-layer investment in clinical AI.

  • Protocol-level play with natural monopoly characteristics — GHARRA aims to become the global trust registry for clinical AI agents, analogous to DNS for the internet or SWIFT for financial messaging
  • Network effects compound with every agent registered, every health system connected, and every clinical delegation routed through the protocol
  • Regulatory tailwinds are structural, not cyclical — the EU AI Act, GDPR, and emerging national AI governance frameworks demand exactly what Symphonix builds
  • Africa represents a $5.6B leapfrog opportunity where Symphonix has first-mover advantage — 1.4 billion people building digital health infrastructure without legacy constraints
  • Infrastructure model proven in healthcare software — free BulletTrain drives adoption; managed GHARRA service and enterprise products capture value
  • Healthcare data breach costs averaging $10.22M per incident create urgent demand for zero-trust agent verification and hash-chained audit infrastructure
  • Dublin headquarters provides GDPR adequacy, EU AI Act compliance, and geographic positioning between the UK, EU, and African health systems
  • Founding team combines deep healthcare domain expertise with infrastructure engineering and healthcare platform development

Intelligent healthcare infrastructure should be available to every health system — not just those with the largest budgets. Open protocols lower the barrier to entry.

The Tredegar Principle — Symphonix Health founding vision
STRATEGIC POSITION

What competitors cannot replicate.

?

No Incumbent Owns This Layer

Epic, Cerner (Oracle Health), and InterSystems dominate EHR. Cloud hyperscalers dominate compute. But nobody owns the trust, discovery, and routing layer for clinical AI agents. This is greenfield infrastructure — and Symphonix is building it with open protocols that invite adoption rather than resist it.

Free BulletTrain as Distribution

BulletTrain is free to install and self-host, meaning any health system, government, or research institution can deploy without procurement friction. The integration bridge connects BulletTrain to GHARRA’s managed service, and Nexus A2A governs the protocol layer. Adoption drives revenue, not the other way around.

Request an investor briefing.

We are building the trust and routing infrastructure for clinical AI. If you invest in healthcare infrastructure, protocol-layer companies, or frontier AI applications, we should talk.

Request Briefing View Market Data

See our platform: Platform Overview • Architecture • About Us